Delivery Order SPE2DB24D1107-SPE2DB25FZFW6
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,254.12 to AmerisourceBergen Drug Corp for Vyvanse 40 mg capsules (100-count units) on September 4, 2025, with completion targeted for September 5, 2025. This firm fixed price delivery order represents a non-set-aside competitive award to support federal pharmaceutical procurement needs. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Vyvanse 40 mg capsules (100-count units) with a ceiling value of $5,486.46. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitive award to this major pharmaceutical distributor. The order is set for ultimate completion on August 8, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,241.46 to AmerisourceBergen Drug Corp for Vyvanse 40 mg capsules (100-count) on July 24, 2025, with an ultimate completion date of July 25, 2025. This firm fixed-price contract represents a competitively awarded, non-set-aside delivery order for pharmaceutical supply to support federal medical procurement needs. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $2,323.60 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 40 mg on August 13, 2025, with an ultimate completion date of August 14, 2025. This competitively awarded, firm fixed price delivery order represents a small-value pharmaceutical procurement with no set-aside designation. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $13,377.00 delivery order to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 20 mg on August 20, 2025, with completion targeted for August 21, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's broader pharmaceutical supply relationship with the...
- The Defense Logistics Agency awarded a delivery order valued at $1,439.22 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 40 mg on May 22, 2025, with completion targeted for May 23, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical supply delivery under the contractor's existing contract vehicle with DLA. This...
- The Defense Logistics Agency awarded a $1,533.96 delivery order to AmerisourceBergen Drug Corp for the supply of Vyvanse 40 mg capsules (100 count) on August 26, 2025, with completion scheduled for August 27, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location in the same city. The award represents a child delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Vyvanse 40 mg capsules (100 count) valued at $1,461.68. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 2, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting the company's demonstrated capability to compete...
- The Defense Logistics Agency awarded a delivery order valued at $2,018.10 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 40 mg on September 10, 2025, with completion scheduled for September 11, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single delivery transaction under AmerisourceBergen's existing contract vehicle with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Vyvanse 40 mg capsules (100-count units) with a ceiling value of $1,220.09. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The order is due for completion by September 15, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- SPE2DB24D1107Indefinite Delivery Contract
- SPE2DB24D1107-SPE2DB25FZFW6Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,337.70 for 100 capsules of Vyvanse 40 mg on July 10, 2025, with an ultimate completion date of July 11, 2025. This firm fixed-price delivery order was awarded competitively with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship with DLA. This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military healthcare programs worldwide. The contract structure allows AmerisourceBergen to serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible ordering of brand-name and generic pharmaceutical products essential to military medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 7/10/25 |